Neumega

{
  "id": "MLC-T-ONC-005752",
  "term": "Neumega",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to increase the number of blood cells, especially platelets, in some cancer patients receiving chemotherapy. Neumega is a form of interleukin-11 (a cytokine normally made by support cells in the bone marrow) that is made in the laboratory. It is a type of biological response modifier. Also called oprelvekin, recombinant human interleukin-11, and rhIL-11.",
  "synonyms": [
    "oprelvekin",
    "recombinant human interleukin-11",
    "rhIL-11"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/neumega/"
}